Literature DB >> 33190197

Anti-MOG-associated demyelinating disorders: two sides of the same coin.

Giorgia Teresa Maniscalco1,2, Lia Allegorico3, Gennaro Alfieri4, Massimo Napolitano4, Angelo Ranieri4, Rosaria Renna4, Giovanna Servillo4, Marianna Pezzella5, Elisa Capone6, Lidia Altomare7, Michele Spiniello7, Sergio Ferrari8, Valentino Manzo4, Sara Mariotto8.   

Abstract

BACKGROUND: Anti-myelin oligodendrocyte glycoprotein antibody-associated disorders (MOGAD) are new emerging diseases with heterogeneous course, treatment, response, and prognosis. CASE REPORT: We herein present 2 cases with antibodies to MOG, one with a cerebellar/brainstem monophasic syndrome which partially improved after treatment, and the other with an optic neuritis onset then relapsed with cortical encephalitis and presented a subsequent complete recovery. We further discuss elements possibly associated with disease heterogeneity and influencing treatment choices.
CONCLUSIONS: MOGAD is an extremely variable disease which can relapse and accumulate disability over time. An early diagnosis and correct timely treatment is fundamental to improve clinical outcome.

Entities:  

Keywords:  Anti-MOG-associated disorders (MOGAD); Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies; Demyelinating diseases; Plasma exchange; Rituximab

Mesh：

Substances：

Year:  2020        PMID： 33190197     DOI： 10.1007/s10072-020-04892-7

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


  10 in total

1.  Neurofilament light chain serum levels reflect disease severity in MOG-Ab associated disorders.

Authors:  Sara Mariotto; Sergio Ferrari; Matteo Gastaldi; Diego Franciotta; Elia Sechi; Ruggero Capra; Chiara Mancinelli; Kathrin Schanda; Daniela Alberti; Riccardo Orlandi; Roberto Bombardi; Luigi Zuliani; Marco Zoccarato; Maria Donata Benedetti; Raffaella Tanel; Francesca Calabria; Francesca Rossi; Antonino Pavone; Luisa Grazian; GianPietro Sechi; Lucia Batzu; Noemi Murdeu; Francesco Janes; Vincenza Fetoni; Daniela Fulitano; Gianola Stenta; Lisa Federle; Gaetano Cantalupo; Markus Reindl; Salvatore Monaco; Alberto Gajofatto
Journal:  J Neurol Neurosurg Psychiatry       Date:  2019-04-05       Impact factor: 10.154

2.  Clinical presentation and prognosis in MOG-antibody disease: a UK study.

Authors:  Maciej Jurynczyk; Silvia Messina; Mark R Woodhall; Naheed Raza; Rosie Everett; Adriana Roca-Fernandez; George Tackley; Shahd Hamid; Angela Sheard; Gavin Reynolds; Saleel Chandratre; Cheryl Hemingway; Anu Jacob; Angela Vincent; M Isabel Leite; Patrick Waters; Jacqueline Palace
Journal:  Brain       Date:  2017-12-01       Impact factor: 13.501

3.  Radiological characteristics of myelin oligodendrocyte glycoprotein antibody disease.

Authors:  Sara Salama; Majid Khan; Michael Levy; Izlem Izbudak
Journal:  Mult Scler Relat Disord       Date:  2019-01-10       Impact factor: 4.339

4.  Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome.

Authors:  John J Chen; Eoin P Flanagan; Jiraporn Jitprapaikulsan; Alfonso Sebastian S López-Chiriboga; James P Fryer; Jacqueline A Leavitt; Brian G Weinshenker; Andrew McKeon; Jan-Mendelt Tillema; Vanda A Lennon; W Oliver Tobin; B Mark Keegan; Claudia F Lucchinetti; Orhun H Kantarci; Collin M McClelland; Michael S Lee; Jeffrey L Bennett; Victoria S Pelak; Yanjun Chen; Gregory VanStavern; Ore-Ofe O Adesina; Eric R Eggenberger; Marie D Acierno; Dean M Wingerchuk; Paul W Brazis; Jessica Sagen; Sean J Pittock
Journal:  Am J Ophthalmol       Date:  2018-07-26       Impact factor: 5.258

5.  Unilateral cortical FLAIR-hyperintense Lesions in Anti-MOG-associated Encephalitis with Seizures (FLAMES): characterization of a distinct clinico-radiographic syndrome.

Authors:  A Budhram; A Mirian; C Le; S M Hosseini-Moghaddam; M Sharma; M W Nicolle
Journal:  J Neurol       Date:  2019-06-26       Impact factor: 4.849

6.  Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults.

Authors:  Alvaro Cobo-Calvo; María Sepúlveda; Hyacintha d'Indy; Thais Armangué; Anne Ruiz; Elisabeth Maillart; Caroline Papeix; Bertrand Audoin; Helene Zephir; Damien Biotti; Jonathan Ciron; Francoise Durand-Dubief; Nicolas Collongues; Xavier Ayrignac; Pierre Labauge; Eric Thouvenot; Alexis Montcuquet; Romain Deschamps; Nuria Solà-Valls; Sara Llufriu; Yolanda Blanco; Jerome de Seze; Sandra Vukusic; Albert Saiz; Romain Marignier
Journal:  J Neurol       Date:  2019-01-03       Impact factor: 4.849

7.  Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders.

Authors:  A Sebastian López-Chiriboga; Masoud Majed; James Fryer; Divyanshu Dubey; Andrew McKeon; Eoin P Flanagan; Jiraporn Jitprapaikulsan; Naga Kothapalli; Jan-Mendelt Tillema; John Chen; Brian Weinshenker; Dean Wingerchuk; Jessica Sagen; Avi Gadoth; Vanda A Lennon; B Mark Keegan; Claudia Lucchinetti; Sean J Pittock
Journal:  JAMA Neurol       Date:  2018-11-01       Impact factor: 18.302

8.  Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study.

Authors:  Alvaro Cobo-Calvo; Anne Ruiz; Elisabeth Maillart; Bertrand Audoin; Helene Zephir; Bertrand Bourre; Jonathan Ciron; Nicolas Collongues; David Brassat; Francois Cotton; Caroline Papeix; Francoise Durand-Dubief; David Laplaud; Romain Deschamps; Mikaël Cohen; Damien Biotti; Xavier Ayrignac; Caroline Tilikete; Eric Thouvenot; Bruno Brochet; Cecile Dulau; Thibault Moreau; Ayman Tourbah; Pierre Lebranchu; Laure Michel; Christine Lebrun-Frenay; Alexis Montcuquet; Guillaume Mathey; Marc Debouverie; Jean Pelletier; Pierre Labauge; Nathalie Derache; Marc Coustans; Fabien Rollot; Jérôme De Seze; Sandra Vukusic; Romain Marignier
Journal:  Neurology       Date:  2018-04-25       Impact factor: 9.910

9.  Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study.

Authors:  Sara Mariotto; Sergio Ferrari; Salvatore Monaco; Maria Donata Benedetti; Kathrin Schanda; Daniela Alberti; Alessia Farinazzo; Ruggero Capra; Chiara Mancinelli; Nicola De Rossi; Roberto Bombardi; Luigi Zuliani; Marco Zoccarato; Raffaella Tanel; Adriana Bonora; Marco Turatti; Massimiliano Calabrese; Alberto Polo; Antonino Pavone; Luisa Grazian; GianPietro Sechi; Elia Sechi; Daniele Urso; Rachele Delogu; Francesco Janes; Luciano Deotto; Morena Cadaldini; Maria Rachele Bianchi; Gaetano Cantalupo; Markus Reindl; Alberto Gajofatto
Journal:  J Neurol       Date:  2017-10-23       Impact factor: 4.849

Review 10.  MOG encephalomyelitis: international recommendations on diagnosis and antibody testing.

Authors:  S Jarius; F Paul; O Aktas; N Asgari; R C Dale; J de Seze; D Franciotta; K Fujihara; A Jacob; H J Kim; I Kleiter; T Kümpfel; M Levy; J Palace; K Ruprecht; A Saiz; C Trebst; B G Weinshenker; B Wildemann
Journal:  J Neuroinflammation       Date:  2018-05-03       Impact factor: 8.322
  10 in total
  1 in total

1.  Myelin Oligodendrocyte Glycoprotein Antibody Associated Cerebral Cortical Encephalitis: Case Reports and Review of Literature.

Authors:  Hang Shu; Manqiu Ding; Pei Shang; Jia Song; Yue Lang; Li Cui
Journal:  Front Hum Neurosci       Date:  2022-01-03       Impact factor: 3.169
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.